Approval Compasses COVID-19 Vaccines For Emergency Use in Pakistan

COVID Vaccines

The calamity brought by novel Covid-19 did not just take the lives to an infinite count but its perpetual grip onto this world has been an alarming situation as the death toll worldwide has reached to 2.06 Million till date. 

According to NCOC (National Command Operation Centre), Pakistan is also such country amongst that informed 11,247 deaths and a day to day increase in cases went up to 530,818 confirmed cases till now. It has seized all its provinces into grip. Whereas, the most affected provinces lined-up are Sindh and Punjab with the rate of 22 deaths per day.

The ongoing waves of Coronavirus even lag behind when a new variant happened to be surfaced in England reached to country and was said to be more transmissible by the Health Authorities in Pakistan.     

However, it seemed to jolt the people in medical capacity worldwide to every extent of their most efforts in bringing the vaccines in progress after multiple pharmaceuticals put their research in.

The Minister of National Health Services, Faisal Sultan announced that DRAP (Drug Regulatory Authority of Pakistan), hailed the first vaccine AztraZeneca for emergency use authorization in country last week. Vaccine developed by Oxford University researchers received approval by the Medicines and Healthcare products Regulatory Agency (MHRA), UK for the full two doses on December 30th, 2020.

The second vaccine Chinese Sinopharm, however also came in queue for the approval by DRAP (Drug Regulatory Authority of Pakistan). The vaccine was developed by Beijing Institute of Biological Products, a subsidiary of state-own conglomerate Sinopharm and was approved by Chinese Health Authorities.

Both the vaccines were evaluated for their safety and quality and green lighted after going through 3 Clinical Trials in Pakistan as per their efficacy generated, 69 to 90 percent for Oxford vaccine and 79 percent for Sinopharm vaccine was confirmed by their respective authorities.

Earlier this year, Federal Minister for Science and Technology, Fawad Chaudary said that Pakistan will purchase 1.2 million COVID vaccine doses from China’s Sinopharm. Nevertheless, Pakistan will also be receiving “in the range of tens of millions” of vaccine doses under an agreement with China’s CanSino Bio, announced Faisal Sultan.

Meanwhile the development of more vaccines like Pfizer and Moderna also emerged as rivals; yet officials showed concern over the advantages and costs follow-ups to procure other vaccines with the passage of time.

On the contrary, all vaccines are said to be equally effective against the new variant of viruses by provoking Immunity.

Government officials have urged the pharmaceutical companies to step in and prepare vaccines for distribution. However, free provision of vaccines in the masses retains a priority stressed by authorities amid the ongoing clinical trials of vaccines at ICCB (International Centre for Chemical and Biological Sciences) and NIH (National Institute of Health) Pakistan.

COVAX facility set up in last April by WHO, GAVI (Global Alliance for Vaccines and Immunization), CEPI (Coalition for Epidemic Preparedness Innovations) has pledged the provision of free vaccines in different countries including Pakistan.   

An important insight by WHO also came across.

WHO (World Health Organization) Director General Head Tedros Adhanom Ghebreyesus

With the progression of Covid’ Vaccines Worldwide, if equitable and fair distribution is not made significance then some of the deprived nations will still be at risk; it will be a ‘Catastrophic Moral Failure’, reflected by WHO (World Health Organization) Director General Head Tedros Adhanom Ghebreyesus.